Contact Us

Contact Us

Please contact us below with any questions

info@quadratech.co.uk

+44 (0)33 3321 2371

Side Contact
×
Sign up to our newsletter Click Here
quadratech Logo
{{ toggleHam ? 'CLOSE' : 'MENU' }}
Next Day & International Delivery
Competitive Pricing
Over 30 Years Experience
Based In The UK

Featured Products

Our Product Ranges

Recieve our latest news

Sign up to our newsletter

Our Company

 

With over 30 years of trading experience, Quadratech Diagnostics Limited has always been and remains committed to providing the highest quality state-of-the-art medical diagnostic and research products. Since the company was founded in 1990, we have expanded to encompass the following main areas: HaemostasisAntigens, Antibodies and ToxinsRapid and POC TestsParasitology and Veterinary.

Quadratech Diagnostics Limited is a corporate member of the Institute of Biomedical Scientists (IBMS) and the British Society for Haemostasis and Thrombosis (BSHT). We are a recognised supplier to the UK National Health Service (NHS), the Irish Health Service Executive (HSE), private laboratories, the UK pharmaceutical industry, and university research groups. Quadratech Diagnostics Limited became incorporated as a limited company in 1998 and is ISO 9001:2015 certified.

Our Product Brands

Latest News

Haemostasis March 2025 News

Our round-up of the latest developments from across the haemostasis industry for March 2025. REGULATORY Genentech’s TNKase (tenecteplase, tissue plasminogen activator) was approved by the FDA for the treatment of acute ischemic stroke (AIS) in adults, administered as a single 5-second intravenous (IV) bolus (3 Mar) Sanofi / Alnylam’s Qfitlia (fitusiran, antithrombin RNAi) was approved by […]

Haemostasis April 2025 Journal Club

Keep informed about evolving science and clinical practice with our March 2025 compilation of the latest studies, guidelines, and perspectives in haemostasis. PERSPECTIVES & REVIEWS Ellsworth P, Chen SL, Jones LA, et al. Acquired hemophilia A: a narrative review and management approach in the emicizumab era. J Thromb Haemost. 2025;23(3):824-835. doi:10.1016/j.jtha.2024.09.04 Reyes Ruiz A, Bhale […]

Parasitology & Mycology March 2025 Journal Club

Keep informed about evolving science and clinical practice with our March 2025 compilation of the latest studies, guidelines, and perspectives in parasitology & mycology. ANISAKIDOSIS Bellini I, Scribano D, Ambrosi C, et al. Anisakis extracellular vesicles elicit immunomodulatory and potentially tumorigenic outcomes on human intestinal organoids. Parasites Vectors. 2024;17, 393. doi:10.1186/s13071-024-06471-7  ASPERGILLOSIS Aufiero MA, Hung L-Y, Herbert DR, […]

Our Accreditations

Receive Our Latest News
Sign Up To Our Newsletter